INS and obesity due to melanocortin 4 receptor deficiency: Consistent with the latter mechanism, we have recently shown that insulin’s ability to promote glucose uptake and oxidation in vitro constitutes a metabolic signature of obesity-associated tumor types [6], suggesting that insulin-lowering therapies may be an attractive approach to slow obesity-associated tumor growth, thereby prolonging the window during which curative therapies may be possible.